FDA.reportPublic FDA data

Yuflyma 100 MG/ML per 0.1 ML Prefilled Syringe

RxCUI
2727423
RxNorm name
Yuflyma 100 MG/ML per 0.1 ML Prefilled Syringe
Display name
Yuflyma 100 MG/ML per 0.1 ML Prefilled Syringe
Full name
Yuflyma 100 MG/ML per 0.1 ML Prefilled Syringe
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:58

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761219Yuflymaadalimumab-aaty351(k) InterchangeableRx2026-08-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
YuflymaADALIMUMAB-AATYCELLTRION USA, Inc.526d626f-8c9f-496c-b838-00a73bb363832026-07-15Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2727423

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
526d626f-8c9f-496c-b838-00a73bb36383Yuflyma 10 MG in 0.1 ML Prefilled Syringe [PSN] · 0.1 ML adalimumab-aaty 100 MG/ML Prefilled Syringe [Yuflyma] [SBD] · Yuflyma 10 MG per 0.1 ML Prefilled Syringe [SY] · Yuflyma 100 MG/ML per 0.1 ML Prefilled Syringe [SY]413These highlights do not include all the information needed to use YUFLYMA safely and effectively. See full prescribing information for YUFLYMA. YUFLYMA (adalimumab-aaty) injection, for subcutaneous use Initial U.S. Approval: 2023 YUFLYMA (adalimumab-aaty) is biosimilar Biosimilar means that the biological product is approved basetd on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences betwe20251028